Gene Signal International SA
PSE, EPFL site
PSE-A - 2nd floor
Responsible Mr. Eric Viaud
Gene Signal is a research and development based biotechnology company focused on discovering genes involved in the regulation of angiogenesis. Gene Signal is currently developing therapeutic solutions based on a family of antisense oligonucleotides (short DNA fragments) to conquer disease associated with significant unmet medical needs despite the advent of VEGF (Vascular Endothelial Growth Factor). Gene Signal is currently completing recruitment for its Phase III study for GS-101 (Aganirsen) in corneal neovascularisation, its most advanced therapeutic ophthalmic solution.
Keywords : Antisense Oligonucleotides, Ophthalmology, Corneal Neovascularisation, Choroidal Neovascularisation